Keywords: Liver, Velocity & Flow
Motivation: To evaluate the potential of portal flow as a biomarker of metabolic-dysfunction associated steatohepatitis (MASH) in obese patients undergoing weight loss surgery (WLS).
Goal(s): Determine feasibility of portal non-contrast 4D Flow in obese patients, to assess whether flow is impacted by BMI and the presence of MASH.
Approach: Portal flow was quantified at 5 timepoints before and after WLS. Mass conservation and inter-observer agreement assessed validation. Results were correlated with BMI and presence/absence of biopsy-proven MASH.
Results: Non-contrast 4D Flow was successful in 339/382 exams (87%); BMI correlated with portal flow (p=0.010); flow was significantly higher in MASH (p=0.013, AUC=0.706)
Impact: Our work demonstrates the feasibility of non-contrast 4D flow in individuals with obesity. Further, it indicates possible effects of obesity on portal venous flow and demonstrates its potential as a treatment monitoring tool in MASH.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords